首页> 外文OA文献 >Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population

【2h】

Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population

机译：血清ProProtein转化酶枯草杆菌素/ kexin型9（PCSK9）与胰岛素抵抗，甘油三酯，脂蛋白（A）水平独立相关，但在一般人群中不是低密度脂蛋白胆固醇水平

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hitoshi Hamamura; Hisashi Adachi; Mika Enomoto; Ako Fukami; Sachiko Nakamura; Yume Nohara; Nagisa Morikawa; Akiko Sakaue; Kenta Toyomasu; Maki Yamamoto; Yoshihiro Fukumoto;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways [J] . CameronJ., BogsrudM.P., TvetenK., Translational research: the journal of laboratory and clinical medicine . 2012,第2期

机译：家族性高胆固醇血症患者的血清原蛋白转化酶枯草杆菌蛋白酶/ kexin 9型水平表明通过低密度脂蛋白受体非依赖性途径从血浆中清除了原蛋白转化酶枯草杆菌蛋白酶/ kexin 9型
2. Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels [J] . Michael T. Lipari, Wei Li, Paul Moran, The Journal of biological chemistry . 2012,第52期

机译：Furin-Creaved Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）是活性的，并调节低密度脂蛋白受体和血清胆固醇水平
3. From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients [J] . Zenti Maria G., Altomari Anna, Lupo Maria G., European journal of preventive cardiology . 2018,第17期

机译：从脂蛋白血液蛋白/ kexin型9型抑制剂：对心血管疾病患者的对低密度脂蛋白胆固醇和C反应蛋白水平的影响
4. Low-density lipoprotein, triglycerides and glycated haemoglobin as metabolic determinant factors of superoxide dismutase circulating levels. [C] . Alonso A., Fabregate M., Fabregate R., International Congress on Coronary Artery Disease . 2009

机译：低密度脂蛋白，甘油三酯和糖化血红蛋白作为超氧化物歧化酶循环水平的代谢决定因子。
5. SERUM HIGH DENSITY LIPOPROTEIN CHOLESTEROL AND TOTAL CHOLESTEROL LEVELS AND OTHER CORONARY HEART DISEASE RISK FACTORS IN RURAL (PREDOMINANTLY AMISH) VERSUS URBAN POPULATIONS [D] . LONDON, CAROLE PAMELA. 1982

机译：农村（主要为阿米什族人）与城市人口的血清高密度脂蛋白胆固醇和总胆固醇水平以及其他冠状动脉疾病的危险因素
6. Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance Triglycerides Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population [O] . Hitoshi Hamamura, Hisashi Adachi, Mika Enomoto, 2021

机译：血清ProProtein转化酶枯草杆菌素/ kexin型9（PCSK9）与胰岛素抵抗甘油三酯脂蛋白（A）水平独立相关但在一般人群中不是低密度脂蛋白胆固醇水平
7. Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels [O] . Michael T. Lipari, Wei Li, Paul Moran, 2012

机译：Furin-Creaved Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）是活性的，并调节低密度脂蛋白受体和血清胆固醇水平

Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population

著录项

引文网络

相似文献

相关主题

期刊订阅